• Mashup Score: 0

    Brandon May is a medical journalist based in Detroit. Upfront therapy comprising human leukocyte antigen (HLA)-haploidentical bone marrow transplantation (BMT) with post-transplantation cyclophosphamide (PTCy) was associated with an overall survival (OS) of greater than 90% at up to three years in pediatric and adult patients with severe aplastic anemia (SAA), with minimal graf t-versus-​host-disease (GVHD), according to study findings published in Blood. The study also demonstrated that the use of

    Tweet Tweets with this article
    • According to findings published in @BloodJournal, upfront therapy comprising HLA-haploidentical #BMT with post-transplant #cyclophosphamide was associated with an OS of greater than 90% in patients with severe #aplastic #anemia, with minimal #GVHD https://t.co/O5MlKCKFkD

  • Mashup Score: 1

    Background Since the publication of the EULAR recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several randomised clinical trials have been published that have the potential to change clinical care and support the need for an update. Methods Using EULAR standardised operating procedures, the EULAR task force undertook a…

    Tweet Tweets with this article
    • #EULAR recommendations for management of ANCA-associated vasculitis eosinophilic granulomatosis polyangiitis eGPA ➡️ Therapy for severe AAV is #cyclophosphamide or #rituximab plus glucocorticoid 👉🏼https://t.co/MVrql0au27 Via @ARD_BMJ @eular_org Via Prof Raashid Luqmani #BSR23 https://t.co/Xz80IYGTWM

  • Mashup Score: 1

    Background Since the publication of the EULAR recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several randomised clinical trials have been published that have the potential to change clinical care and support the need for an update. Methods Using EULAR standardised operating procedures, the EULAR task force undertook a…

    Tweet Tweets with this article
    • #EULAR recommendations for management of #ANCA-associated vasculitis granulomatosis polyangiitis (GPA), microscopic polyangiitis (MPA) ➡️ Therapy for severe AAV is #cyclophosphamide or #rituximab plus glucocorticoids 👉🏼https://t.co/MVrql0au27 Via Prof Raashid Luqmani #BSR23 https://t.co/QimOnOvGTu

  • Mashup Score: 1

    In patients with granulomatosis with polyangiitis, those who start induction therapy with rituximab are more likely to achieve remission compared with those who begin cyclophosphamide, according to data published in JAMA Network Open.

    Tweet Tweets with this article
    • ICYMI: In patients with granulomatosis with polyangiitis, those who start induction therapy with #rituximab are more likely to achieve remission compared with those who begin #cyclophosphamide #MedTwitter #RheumTwitter https://t.co/kJDcwMUUaX

  • Mashup Score: 0

    In patients with granulomatosis with polyangiitis, those who start induction therapy with rituximab are more likely to achieve remission compared with those who begin cyclophosphamide, according to data published in JAMA Network Open.

    Tweet Tweets with this article
    • In patients with granulomatosis with polyangiitis, those who start induction therapy with #rituximab are more likely to achieve remission compared with those who begin #cyclophosphamide #MedTwitter #RheumTwitter https://t.co/kJDcwMUUaX

  • Mashup Score: 12

    Background and Objectives Anti-N-methyl d-aspartate receptor (NMDAR) encephalitis classically affects women of childbearing age, producing a disproportionate number of pregnant women with anti-NMDAR encephalitis. The typical presentation includes progressive neuropsychiatric symptoms, seizures, and alterations in consciousness, all of which present potential risks to the fetus. First-line and…

    Tweet Tweets with this article
    • This case illustrates the effective use of #cyclophosphamide in the second trimester of pregnancy for anti-NMDAR #encephalitis. Read the open access article: https://t.co/6bZuWVf7Ol #NeuroTwitter https://t.co/4Dse5fmuGV